Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer
Daraxonrasib significantly improves survival, disease control, and quality of life in metastatic pancreatic cancer, marking a major advance in targeted second-line treatment options.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.